Agnes Crnic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Agnes Crnic has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Fedja A. Rochling
Gastroenterology and Hepatology, University of Nebraska Medical Center, Omaha, USA
2 shared publications - John P. Gallagher
University of Nebraska Medical Center
2 shared publications Patrick A. Twohig
The University of Nebraska Medical Center
1 shared publication- Patrick Twohig
Department of Gastroenterology and Hepatology, University of Rochester Medical Center, Rochester, NY 14682, United States.
1 shared publication
Latest Publications
- 29 May 2024
- Published by Springer Nature
- p. 127-144
Illicit Drugs and Candidates for Endoscopy and Surgery
- 29 May 2024
- Published by Springer Nature
- p. 127-144
Illicit Drugs and Candidates for Endoscopy and Surgery
- 22 July 2022
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 67 (12) , 5371-5381
Illicit Drug Use and Endoscopy: When Do We Say No?
Background Illicit drug use (IDU) is often encountered in patients undergoing elective ambulatory surgical procedures such as endoscopy. Given the variety of systemic effects of these drugs, sedation and anesthetics are believed to increase the risk of cardiopulmonary complications during procedures. Procedural cancelations are common, regardless of the drug type, recency of use, and total dosage consumed. There is a lack of institutional and society recommendations regarding the optimal approach to performing outpatient endoscopy on patients with IDU. Aim To review the literature for current recommendations regarding the optimal management of outpatient elective endoscopic procedures in patients with IDU. Secondary aim is to provide guidance for clinicians who encounter IDU in endoscopic practice. Methods Systematic review of PubMed, CINAHL, Embase, and Google Scholar for articles presenting data on outcomes of elective procedures in patients using illicit drugs. Results There are no clinically relevant differences in periprocedural complications or mortality in cannabis users compared to non-users. Endoscopy in patients with remote cocaine use was also found to have similar outcomes to recent use. Conclusions Canceling endoscopic procedures in patients with recent IDU without consideration of the type of drug, dosage, and chronicity may lead to unnecessary delays in care and increased patient morbidity. Healthcare systems would benefit from additional guidelines for evaluating the patient with recent illicit drug use for acute intoxication and consider proceeding with procedures in the non-toxic population.
- 22 July 2022
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 67 (12) , 5371-5381
Illicit Drug Use and Endoscopy: When Do We Say No?
Background Illicit drug use (IDU) is often encountered in patients undergoing elective ambulatory surgical procedures such as endoscopy. Given the variety of systemic effects of these drugs, sedation and anesthetics are believed to increase the risk of cardiopulmonary complications during procedures. Procedural cancelations are common, regardless of the drug type, recency of use, and total dosage consumed. There is a lack of institutional and society recommendations regarding the optimal approach to performing outpatient endoscopy on patients with IDU. Aim To review the literature for current recommendations regarding the optimal management of outpatient elective endoscopic procedures in patients with IDU. Secondary aim is to provide guidance for clinicians who encounter IDU in endoscopic practice. Methods Systematic review of PubMed, CINAHL, Embase, and Google Scholar for articles presenting data on outcomes of elective procedures in patients using illicit drugs. Results There are no clinically relevant differences in periprocedural complications or mortality in cannabis users compared to non-users. Endoscopy in patients with remote cocaine use was also found to have similar outcomes to recent use. Conclusions Canceling endoscopic procedures in patients with recent IDU without consideration of the type of drug, dosage, and chronicity may lead to unnecessary delays in care and increased patient morbidity. Healthcare systems would benefit from additional guidelines for evaluating the patient with recent illicit drug use for acute intoxication and consider proceeding with procedures in the non-toxic population.